Elevated Ferritin in Polycythemia Vera
In polycythemia vera (PV), elevated ferritin is uncommon and should prompt investigation for causes unrelated to the PV itself, as PV patients are characteristically iron deficient due to increased erythropoiesis and therapeutic phlebotomy.
Understanding the Paradox
PV presents a unique iron metabolism scenario that differs fundamentally from other conditions:
- PV patients are typically iron deficient, not iron overloaded 1, 2
- Iron deficiency occurs at presentation in virtually all PV patients and worsens with standard phlebotomy therapy 1
- Serum ferritin levels in untreated PV are normal or slightly decreased 3
- The combination of polycythemia with iron deficiency represents a physiological disconnect, as the body attempts to produce excessive red cells despite inadequate iron stores 1
Evaluation Algorithm for High Ferritin in PV
When encountering elevated ferritin in a PV patient, follow this systematic approach:
1. Assess for Inflammation or Infection
Ferritin is an acute phase reactant that rises with inflammation regardless of true iron status 4. Check:
- C-reactive protein (CRP)
- Erythrocyte sedimentation rate (ESR)
- White blood cell count with differential
- Clinical signs of infection or inflammatory conditions
2. Evaluate Transferrin Saturation (TSAT)
The combination of ferritin and TSAT provides critical diagnostic information 4:
- TSAT <20% with elevated ferritin: Suggests functional iron deficiency with inflammation (ferritin elevated as acute phase reactant, not reflecting true iron stores)
- TSAT >50% with elevated ferritin: Consider true iron overload from alternative causes
3. Consider Alternative Diagnoses
Transfusion-related iron overload:
- Review transfusion history
- In transfusion-dependent patients, ferritin >1,000 ng/mL indicates secondary iron overload 5
- This is uncommon in PV unless the patient has received multiple transfusions
Hereditary hemochromatosis:
- Screen for HFE mutations (C282Y, H63D)
- Check family history
- Evaluate for end-organ damage (liver, heart, pancreas) 6, 7
Liver disease:
- Assess liver function tests
- Consider hepatitis screening
- Evaluate for alcohol use or non-alcoholic fatty liver disease 8
Blastic transformation:
- Highly elevated ferritin (>30-fold increase) can indicate progression to acute leukemia 3
- Check complete blood count with differential
- Consider bone marrow examination if blast cells present
Management Approach
If Ferritin Elevation is Due to Inflammation:
- Continue standard PV therapy with phlebotomy targeting hematocrit <45% 9
- Treat underlying inflammatory condition
- Monitor TSAT as the more reliable indicator of functional iron availability 4
- Consider soluble transferrin receptor (sTfR) if available, as it remains elevated in iron deficiency despite inflammation 4
If True Iron Overload is Confirmed:
This scenario is rare in PV but requires specific management:
For transfusion-related overload:
- Consider iron chelation therapy if ferritin persistently >1,000 ng/mL with ongoing transfusion needs 5
- Options include deferoxamine or deferasirox 7
For hereditary hemochromatosis coexisting with PV:
- Therapeutic phlebotomy serves dual purpose (controls hematocrit AND removes excess iron) 6, 7
- Target ferritin 50-100 μg/L during maintenance phase 6, 7
- Monitor more frequently as phlebotomy requirements may differ from standard PV management
Optimizing PV Management to Prevent Iron Deficiency Complications:
The standard phlebotomy approach exacerbates iron deficiency 1, 2, causing:
- Fatigue and lethargy
- Impaired concentration
- Reduced quality of life
Consider alternative strategies for high-risk patients:
- Cytoreductive therapy (hydroxyurea or interferon) reduces phlebotomy requirements 9
- Ruxolitinib for hydroxyurea-resistant cases 9
- Rusfertide (hepcidin mimetic) represents a novel approach that controls hematocrit without phlebotomy by limiting iron availability to erythropoiesis 10, 2
Key Monitoring Parameters
- Ferritin should be interpreted alongside TSAT, never in isolation 4
- In the absence of inflammation, goal ferritin is 50 ng/mL 4
- With inflammation present, ferritin <100 ng/mL still suggests iron deficiency 4, 8
- Avoid checking iron parameters within 4 weeks of phlebotomy or IV iron administration, as circulating iron interferes with assays 4
Critical Pitfalls to Avoid
Do not assume elevated ferritin means adequate iron stores in PV - inflammation commonly elevates ferritin while true iron deficiency persists 4, 1
Do not withhold phlebotomy based solely on elevated ferritin - hematocrit control to <45% remains the priority for thrombosis prevention 9
Do not supplement iron in PV patients - this worsens the underlying disease by fueling erythrocytosis 6, 7
Do not ignore extremely elevated ferritin - values >30-fold normal may indicate blastic transformation requiring urgent evaluation 3